462 125 mg (Emend 125 mg)
Generic Name: aprepitant
Pill imprint 462 125 mg has been identified as Emend 125 mg.
Emend is used in the treatment of nausea/vomiting, chemotherapy induced; nausea/vomiting, postoperative and belongs to the drug class NK1 receptor antagonists. There is no proven risk in humans during pregnancy. Emend 125 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- aprepitant
- Imprint:
- 462 125 mg
- Strength:
- 125 mg
- Color:
- Pink & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- NK1 receptor antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Merck & Company Inc.
- National Drug Code (NDC):
- 00006-0462
- Inactive Ingredients:
- sucrose
microcrystalline cellulose
hydroxypropyl cellulose (type h)
sodium lauryl sulfate
gelatin
titanium dioxide
silicon dioxide
ferric oxide red
ferric oxide yellow
More about Emend (aprepitant)
Consumer resources
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
